Orthofix falls 10% to 52-week low after analyst downgrade

Orthofix International N.V. (Nasdaq:OFIX) is down more than 10% today after analysts at Wachovia downgraded the orthopedics products company to “market perform” from “outperform.” The downgrade came on concerns of difficulties in the company’s spine distributor base and the loss of its stem cell biologic Trinity. The Netherlands-based company has fallen to a 52-week low on the downgrade. Shares of Orthofix International are down $2.89 to $25.15 in below-average volume at 11:00 ET. The company fell to a low for the year of $25.05 earlier in today’s trading.

For detailed price information and recent news stories on Orthofix International N.V., click OFIX.

---